Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: Recent data from the czech leukemia study group for life (CELL)

Clinical Lymphoma, Myeloma and Leukemia

Volumn 10, Issue 4, 2010, Pages 297-300

  Panovská, Anna ^a   Doubek, Michael ^a   Brychtová, Yvona ^a   Mayer, Jiêí ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Alemtuzumab; Cyclophosphamide; Doxorubicin; Prednisolone; Prednisone; Vincristine

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; OFATUMUMAB; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; CZECH REPUBLIC; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; HEMATOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; EPILUMINESCENCE MICROSCOPY; TREATMENT RESPONSE;

EID: 85047684832     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2010.n.061     Document Type: Article

References (11)

1. National Cancer Institute. Chronic Lymphocytic Leukemia Treatment (PDQ®): Stage Information. Cancer.gov. Available at: http://www.cancer.gov/ cancertopics/pdq/treatment/CLL/healthprofessional/page2. Accessed: May 6, 2010.
2. Redaelli A, Laskin BL, Stephens JM, et al. The clinical and epidemiological burden of chronic lymphocytic leukemia. Eur J Cancer Care (Engl) 2004; 13:279-87. (Pubitemid 38834460)
3. Ries LA, Melbert D, Krapcho M, et al SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Cancer.gov [Web site]. Available at: http://seer.cancer. gov/csr/1975-2005/. Accessed: May 6, 2010.
4. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in 5 Continents: Vol. VII (IARC Scientific Publication). Oxford University Press. 1286s.
5. Morton LM, Wang SS, Devesa SS. Lymphoma incidence patterns by WHO subtype in United States, 1992-2001. Blood 2006; 107:265-76.
6. Sgambati MT, Linet MS, Devesa SS. Chronic lymphocytic leukemia. Epide-miological, familial, and genetic aspects. In: Cheson BD ed. Chronic Lymphoid Leukemias. 2nd ed. New York, NY: Marcel Dekker; 2001:33-62.
7. Rawstron AC, Green MJ, Kuzmicki A, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100:635-9.
8. Census and Housing 2001. South Moravian Region, NUTS 4: CZ0620. Available at: http://www.czso.cz/sldb/sldb2001.nsf/tabx/CZ0620. Accessed: May 6, 2010.
9. Halek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 Guidelines. Blood 2008; 111: 5446-5456.
10. Zent CS, Kyasa MJ, Evans R, et al. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001; 92:1325-30.
11. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343:1910-6. (Pubitemid 32064784)